F81. ELUCIDATING GENETIC AND ENVIRONMENTAL RISK FACTORS FOR ANTIPSYCHOTIC-INDUCED METABOLIC ADVERSE EFFECTS USING ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN THE MILLION VETERAN PROGRAM
Ayman H. Fanous(University of Arizona), Beauty Kolade(Los Alamos National Laboratory), Silviu‐Alin Bacanu, Sutanay Choudhury, Philip D. Harvey(University of Miami), Benjamin McMahon(Los Alamos National Laboratory), Julie Kreyenbuhl(University of Maryland, Baltimore), Stephen R. Marder(West Los Angeles College), Hamed Abbaszadegan(Phoenix VA Health Care System), Khushbu Agarwal, Ham Colby(Pacific Northwest National Laboratory), Sayera Dhaubhadel(Los Alamos National Laboratory)
Cited by 0
Related Papers
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|915
The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|781
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003
|Schizophrenia Bulletin|2004|768